17,261 trials
Chronic Obstructive Pulmonary Disease
Primary: Baseline Pre-bronchodilator FEV1 (L) — 1.51; 1.47; 1.50; 1.51 L
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Baseline Pre-bronchodilator FEV1 (L) — 1.49; 1.44 L
Myelofibrosis · Polycythemia Vera · Thrombocytosis
Primary: Number of Participants With Adverse Events (AEs) — 30; 35; 47; 5 participants
Endometrial Carcinoma
Primary: Determination (for ITT (Intet-to-Treat Set): Efficacy of a Monthly Administration of Fulvestrant in Patients With Recurrent or Metastatic Endometrial Carcinoma by…
Renal Transplant
Primary: Incidence of Allograft Rejection — 13 participants
Multiple Myeloma · Refractory Multiple Myeloma · Stage I Multiple Myeloma
Primary: Number of Patients Achieving 3 Million CD34 Cells/kg After 2 Days of Apheresis — 38 participants
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma · Recurrent Metastatic Squamous Neck Cancer With Occult Primary · Recurrent Salivary Gland Cancer
Primary: Number of Participants With Progression-free Survival at 12-weeks — 1 participants
Anemia
Primary: Mean Change in Hemoglobin Between Baseline and the Evaluation Period — 11.22; 11.11; 10.78; 11.64 g/dL
Chronic Hepatitis C
Primary: Patients With Either Undetectable Serum HCV RNA (<100 Copies/ml) or at Least a 2-log Decrease From Baseline in Serum Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) at…
Schizophrenia
Primary: Mean Change in Negative Scale Scores From the Positive and Negative Syndrome Scale (PANSS) From Baseline to Endpoint — -2.0; -2.3; -2.1; -2.1 Units on a scale — p=0.8514
Influenza
Primary: Number of Subjects Reporting Any and Grade 3 Solicited Local Symptoms — 0; 1; 0; 0 Subjects
Crohn's Disease
Primary: Number of Participants With Clinical Response at Week 6 — 31; 48; 45; 52 Participants — p=0.005
Myelodysplastic Syndrome · Leukemia
Primary: Number of Participants With Response for Two Dose Schedules of Clofarabine — 10; 5; 5; 1 Participants
Alzheimer's Disease
Primary: Differences in Standard Uptake Value Ratio (SUVR) for Frontal Cortex/Cerebellum and Whole Brain/Cerebellum of the Positron Emission Tomography (PET) Scan With…
Impaired Glucose Tolerance · Obstructive Sleep Apnea
Primary: Number of Subjects With Normalization of Impaired Glucose Tolerance (IGT) — 7; 5 subjects — p=0.57